Abstract
INTRODUCTION: Fear strikes and reluctancy appears in many type-2 diabetes patients (T2DM) when they heard about starting insulin treatment. Insulin treatment initiation is a challenge for both health care providers and diabetes patients as well. This study aims to identify the association between emotional factor and psychological insulin resistance (PIR) among T2DM patients. METHODS: A cross-sectional study using interviewer assisted questionnaires was conducted among insulin naïve T2DM patients in government health clinics at a district of Penang, Malaysia. Insulin Treatment Appraisal Scale (ITAS) was used to assess PIR. RESULTS: Among 385 respondents, 280 (72.7%) were reluctant to initiate insulin treatment, female (77.1%) had higher PIR as compared to male (64.7%). The matter that the respondents feared the most was the fear of self-injection (60.8%), this was followed by the needle phobia (53.5%), fear of pain (51.4%), and afraid of hypoglycaemia attack after starting insulin treatment (49.9%). The fear of weight gain, blood phobia, and fear of self-monitoring of blood glucose (SMBG) were just occurred among 33.0%, 25.7%, and 21.3% of the respondents. Simple linear regression showed that there was a significant direct linear association between PIR with emotional factor (Beta= 0.562, p<0.001). With 1 unit increased in emotional factor, there was 0.999 increased in PIR (T=13.302, F(1,383)=176.945). Emotional factor explained 31.6% of the total variance in psychological insulin resistance among the insulin naive T2DM patients at the studied health clinics. CONCLUSION: Therefore, tackling the fears of patients is fundamental to reduce PIR among T2DM patients.
Links
BibTeX (Download)
@proceedings{APCPH-2019-313,
title = {What Fears the Type-2 Diabetes Patients to Start on Insulin Treatment?},
author = {Chia Yee Kang and Salmiah Md Said and Rosliza Abdul Manaf},
year = {2019},
date = {2019-07-22},
urldate = {2019-07-22},
journal = {6th Asia-Pacific Conference on Public Health 2019 Proceedings},
issue = {6},
abstract = {INTRODUCTION: Fear strikes and reluctancy appears in many type-2 diabetes patients (T2DM) when they heard about starting insulin treatment. Insulin treatment initiation is a challenge for both health care providers and diabetes patients as well. This study aims to identify the association between emotional factor and psychological insulin resistance (PIR) among T2DM patients. METHODS: A cross-sectional study using interviewer assisted questionnaires was conducted among insulin na\"{i}ve T2DM patients in government health clinics at a district of Penang, Malaysia. Insulin Treatment Appraisal Scale (ITAS) was used to assess PIR. RESULTS: Among 385 respondents, 280 (72.7%) were reluctant to initiate insulin treatment, female (77.1%) had higher PIR as compared to male (64.7%). The matter that the respondents feared the most was the fear of self-injection (60.8%), this was followed by the needle phobia (53.5%), fear of pain (51.4%), and afraid of hypoglycaemia attack after starting insulin treatment (49.9%). The fear of weight gain, blood phobia, and fear of self-monitoring of blood glucose (SMBG) were just occurred among 33.0%, 25.7%, and 21.3% of the respondents. Simple linear regression showed that there was a significant direct linear association between PIR with emotional factor (Beta= 0.562, p\<0.001). With 1 unit increased in emotional factor, there was 0.999 increased in PIR (T=13.302, F(1,383)=176.945). Emotional factor explained 31.6% of the total variance in psychological insulin resistance among the insulin naive T2DM patients at the studied health clinics. CONCLUSION: Therefore, tackling the fears of patients is fundamental to reduce PIR among T2DM patients.},
note = {Type: POSTER PRESENTATION; Organisation: Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia, Ministry of Health Malaysia, Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia},
keywords = {emotional factor, fear, ITAS, psychological insulin resistance, type-2 diabetes},
pubstate = {published},
tppubtype = {proceedings}
}